HNF4A Gene Maturity-Onset Diabetes of the Young Type 1 (MODY1) Genetic Test in Dubai, UAE

Executive Summary & Core Metrics

Diagnostic Accuracy: 99.9% sensitivity via ISO 9001:2015 accredited Next‑Generation Sequencing with full gene coverage and copy number variant analysis.

Turnaround Time: 3–4 weeks from sample receipt to comprehensive clinical report.

Sample Types: Whole blood (EDTA), extracted DNA, or dried blood spot (FTA card) – all accepted with validated cold‑chain logistics.

Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection available daily 8 AM–11 PM.

Post‑Test Support: Telephonic expert interpretation by DHA‑licensed medical geneticists and genetic counselors.

Insurance: Direct billing verification via WhatsApp +971 54 548 8731.

Test Overview & Methodology

The HNF4A Gene Maturity‑Onset Diabetes of the Young Type 1 (MODY1) Genetic Test provides definitive molecular diagnosis of this monogenic diabetes subtype using high‑resolution Next‑Generation Sequencing (NGS) on the Illumina® platform. The assay covers the entire HNF4A coding region, splice sites, and flanking intronic regions, including copy number variant detection. All pathogenic variants are confirmed by Sanger sequencing. The test enables precise diabetes subclassification, guides targeted sulfonylurea therapy, and identifies at‑risk family members.

Feature	Our Premium NGS Test	Standard MODY1 Testing
Diagnostic Precision	99.9% Sensitivity – Full gene coverage with deep NGS & copy number variant analysis	Variable; often limited to hotspot mutation panels/Sanger sequencing
Methodology	Next‑Generation Sequencing (NGS) on Illumina® platform, validated by Sanger confirmation	Sanger sequencing; may miss large deletions/duplications
Turnaround Time	3–4 Weeks with ISO 9001:2015 certified cold‑chain logistics	Often 6–8 Weeks, with non‑specialized transport
Sample Types Accepted	Whole Blood, Extracted DNA, Dried Blood Spot (FTA Card) – all with stable transport	Usually only whole blood or extracted DNA
Clinical Reporting	DHA‑Compliant report with ICD‑10 coding, personalized risk assessment & genetic counseling referral	Basic mutation report without regulatory coding

Physician Insight & Safety Protocols

“A positive HNF4A mutation confirms MODY1, offering clarity for a condition often misdiagnosed as Type 1 or Type 2 diabetes. Genetic results must always be interpreted alongside your clinical picture and family history. Pre‑test genetic counseling is essential to ensure informed decision‑making.”

— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403

⚠ Medication Advisory

Do not discontinue prescribed diabetes medication or insulin without consulting your physician. Altering therapy based solely on a genetic report can lead to serious metabolic complications.

Patient Exclusion Criteria & Safety

Conditions Requiring Postponement or Clearance

Active febrile illness or acute infection – postpone blood draw until recovery.
Known severe anemia (Hb < 8 g/dL) or bleeding diathesis – physician clearance required.
Unwillingness to undergo mandatory pre‑test genetic counseling (required by UAE Federal Decree‑Law No. 4 of 2016 on Medical Liability for minors).
Inability to provide informed consent (legal guardian must be present).
Pregnancy is not a contraindication, but inform the phlebotomist of your status.

Emergency Red Flags – Seek Immediate Medical Attention

Fruity‑smelling breath, deep rapid breathing, or confusion (possible diabetic ketoacidosis).
Blood glucose persistently > 250 mg/dL with nausea/vomiting.
Sudden vision loss or altered consciousness.
Severe dehydration or inability to keep fluids down.

Patient FAQ & Clinical Guidance

1. What is the HNF4A MODY1 test and why is it crucial for UAE families?

This NGS‑based genetic test analyzes the entire HNF4A gene to identify pathogenic variants causing maturity‑onset diabetes of the young type 1, enabling precise diabetes subclassification and targeted sulfonylurea therapy. Many individuals with MODY1 are initially misdiagnosed with Type 1 or Type 2 diabetes, leading to unnecessary insulin therapy. Accurate genetic diagnosis allows more effective oral treatment and informs family screening.

2. How is the sample collected and what are the requirements?

A certified mobile phlebotomist collects blood (EDTA tube), extracted DNA, or a simple finger‑prick dried blood spot (FTA card) during a scheduled home visit. All samples are transported under ISO 9001:2015 validated cold‑chain conditions. For best DNA quality, fasting is not required, but avoid heavy meals immediately before collection. Results are typically available in 3–4 weeks.

3. What legal protections apply to my genetic data in the UAE?

Your genomic information is protected under UAE Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All data is stored on encrypted, DHA‑compliant servers with strict access controls. Genetic results are only shared with your consent and are used exclusively for diagnostic and therapeutic purposes.

UAE Regulatory & Data Privacy Adherence

DNA Labs UAE operates under DHA Facility License No. 1143 and complies fully with UAE Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic testing procedures adhere to Federal Decree‑Law No. 4 of 2016 on Medical Liability, ensuring patient safety and informed consent. Your data is encrypted, access‑controlled, and never shared without your explicit authorization.

Clinical & Logistical Metadata

Test Name	HNF4A Gene Maturity‑Onset Diabetes of the Young Type 1 (MODY1) Genetic Test
Price (AED)	2,800
Turnaround Time	3–4 Weeks from sample receipt
Sample Type / Matrix	Whole Blood (EDTA), Extracted DNA, Dried Blood Spot (FTA Card)
Methodology Used	Next‑Generation Sequencing (NGS) on Illumina® platform with Sanger confirmation
ICD-10-CM Code	E11.8 (Diabetes mellitus due to genetic defect of beta‑cell function)
LOINC Code	80773-4 (HNF4A gene full sequencing)
DHA Facility License & Laboratory Address	License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE